Zensights appoints Roderick Cavin as director
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Zensights LLC is pleased to announce that Roderick Cavin has joined the organization as a Director. Rod is a recognized leader in the biopharmaceutical and medical device markets with deep expertise and knowledge in accessing the US and European markets. He has engaged with clients ranging from big pharma to start-up device companies in product launch, organizational design, market access/pricing, vendor selection and large customer engagement. Additionally, he brings the unique experience of having successfully built and sold a leading syndicated research and data business.
Rod is a welcome addition to the Zensights team and brings experience driving sustainable customer growth by identifying key business challenges and linking strategy to tactical plans with clear metrics. In this new role, Rod will lead client engagements and support the growth of multi-client product platforms.
Bob Jansen, CEO of Zensights, said, “Rod has extensive payer experience and has supported pharmaceutical and biotech companies through all phases of their growth trajectory. His knowledge and understanding of the payer landscapes in the US and EU will prove extremely valuable to our clients. »
Founded in 2012, Zensights is focused on helping biopharmaceutical organizations improve their business results by building relationships with “Best in Class” suppliers from a “capability-by-capability” perspective. For pharma and biotech business leaders looking to optimize services using a new or existing supplier partner, Zensights provides software, advanced consulting, verification and executive connections to help business and supply partners obtain high quality services, adapted to their needs and profitable. contracts and solutions to drive business results.